Both in Pharmaceuticals
ANI Pharmaceuticals vs Ultragenyx Pharmaceutical
Over the past year ANIP returned −23.8% and RARE returned −49.6%; their daily moves had a correlation of 0.13.
ANIP −23.8% RARE −49.6%Growth of $1, one year, split-adjusted
| Metric | ANIP | RARE |
|---|---|---|
| Price | $71.71 | $16.86 |
| Market cap | $1.65B | $1.66B |
| Today | +1.47% | +3.40% |
| 1 month | −1.2% | +16.2% |
| 6 months | −15.3% | −32.6% |
| Year to date | −9.2% | −26.7% |
| 1 year | −20.8% | −51.3% |
| Revenue growth (YoY) | +25.9% | +28.1% |
| Gross margin | 62.4% | 84.1% |
| Net margin | 8.6% | −43.0% |
| P/E (TTM) | 16.5× | — |
| Price / sales | 1.7× | 2.3× |
| Net cash | -$234.7M | $292.0M |
| Dividend yield | — | — |
| Volatility (60d) | 26.6% | 128.5% |
| Short % of float | 18.1% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).